Scientists Develop Novel Drug That Could Potentially Treat Liver Cancer More Effectively

Source: National University of Singapore

Summary: A research team has developed a novel peptide drug called FFW that could potentially stop the development of hepatocellular carcinoma (HCC), or primary liver cancer.

Hepatocellular carcinoma

Professor Daniel Tenen (right) and Dr. Liu Bee Hui (left), who are researchers from the Cancer Science Institute of Singapore at the National University of Singapore, are members of the research team that had developed a novel peptide drug that could potentially treat liver cancer more effectively. Credit: National University of Singapore

More Information: Bee Hui Liu et al, “Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide”, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1801253115 

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *